HESI RN
Reproductive System Exam Questions
1. In 1989, the national population policy was formally launched targeting:
- A. Reducing population growth
- B. Making family planning services available
- C. Making services accessible and affordable to all eligible users
- D. All of the above
Correct answer: D
Rationale: The correct answer is D because the national population policy launched in 1989 aimed at reducing population growth by making family planning services available, accessible, and affordable to all eligible users. Choice A is incorrect as it does not encompass the full scope of the policy objectives. Choice B is also incomplete as it focuses solely on availability without considering accessibility and affordability. Choice C is partially correct but lacks the comprehensive approach of the national population policy.
2. The letter 'T' in the Acronym 'GATHER' denotes:
- A. Ask the client about themselves - particular needs, obstetric and medical history
- B. Tell the client about modern FP methods available, and discuss each in detail
- C. Help the client choose a method and repeat information regarding the chosen method if necessary
- D. Explain how to use the method - what, where, when, and how
Correct answer: B
Rationale: The correct answer is B: 'Tell the client about modern FP methods available, and discuss each in detail.' In the GATHER acronym, 'T' stands for providing information about modern family planning methods to the client and having a detailed discussion. Choices A, C, and D are incorrect because they do not accurately represent the 'T' component in the GATHER approach. Choice A focuses more on gathering information from the client, choice C is about helping the client choose a method, and choice D is about explaining how to use the method, none of which align with the 'T' in GATHER.
3. What is one role of the hormone estrogen?
- A. Stimulates the development of the milk-producing tissue.
- B. Stimulates the production of lactoferrin.
- C. Stimulates the development of the nipple and duct system in the breast.
- D. Stimulates the secretion of relaxin.
Correct answer: A
Rationale: The correct answer is A: Estrogen stimulates the development of the milk-producing tissue in the breast. This hormone is essential in preparing the breast for milk production. Choice B is incorrect because lactoferrin production is not a primary role of estrogen. Choice C is incorrect as estrogen primarily influences the development of the breast tissue rather than specifically the nipple and duct system. Choice D is incorrect because relaxin secretion is not a function typically associated with estrogen.
4. Approximately how many primordial follicles are present in the cortex of the ovary at birth?
- A. 250,000
- B. 200,000
- C. 150,000
- D. 100,000
Correct answer: A
Rationale: The correct answer is A: 250,000. At birth, there are approximately 250,000 primordial follicles in the cortex of each ovary. These primordial follicles represent the reserve of oocytes that a female will have throughout her reproductive life. Choice B, 200,000, is incorrect as the number is higher. Choices C and D, 150,000 and 100,000 respectively, are also incorrect as they underestimate the actual number of primordial follicles present at birth.
5. Which of the following investigations is done in Pelvic Inflammatory Disease?
- A. Paracentesis
- B. Culdocentesis
- C. Hysterectomy
- D. Douching
Correct answer: B
Rationale: Culdocentesis is the correct procedure performed to assess the pelvic cavity, often used in the diagnosis of Pelvic Inflammatory Disease. Paracentesis involves the aspiration of fluid from the abdominal cavity, not typically done for PID. Hysterectomy is the surgical removal of the uterus and is not a diagnostic investigation for PID. Douching is a hygiene practice and not a diagnostic procedure for PID.
Similar Questions
Access More Features
HESI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access